STUDY TO COMPARE SAFETY & EFFICACY OF ULTRASE MT20 IN CF

研究比较安全性

• 批准号: 7625794
• 负责人: Gavin R Graff
• 金额: $ 1.63万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625794
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Effectiveness; Funding; Grant; Institution; Marketing; Medical center; Pancreatic enzyme; Purpose; Research; Research Personnel; Research Project Grants; Resources; Safety; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research is to obtain information on the safety and effectiveness of Ultrase MT20, a pancreatic enzyme that is already on the market. Approximately 24 people will take part in this research project nationwide and about two people will take part at Hershey Medical Center.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是获取有关 Ultrase MT20（一种已上市的胰酶）的安全性和有效性的信息。全国范围内约有 24 人将参与该研究项目，其中好时医疗中心将有约 2 人参与。